Please correct me if i'm wrong but per Ann on 30th January:
"The Orders are for the ‘Prizma’ Medical Smartphone Case (PRIZMA), as well as G Medical’s Vital SignsMonitoring System (VSMS or G Medical Patch (GMP)) over a 24-month term, commencing on
1 April2019, for aggregate payments of up to ~US$21.85 million. Payments are
scheduled to be made on amonthly basis of amounts varying between approximately US$90,000 and US$1.33 million"
These payments would then mean that we will have enough cash moving forward during the next quarter based on released figures today...
I think this is a very strong update, yes we always want the REV numbers to be bigger but just look at how much is going on, with completed pilot programs, dual listings, final stages of CFDA which is running in parallel to patch approval etc etc, please read the ann again if you are just focuing on 1 quarter of numbers.
I also just added more shares
![Smile](styles/default/xenforo/clear.png)